---All---
  • ---All---
  • Accession
  • Catalog #

SLC44A1 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP14061c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP14061c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

SLC44A1 Antibody (Center) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ8WWI5
Other AccessionNP_536856.2
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW73302 Da

SLC44A1 Antibody (Center) - Additional info

Gene ID 23446
Other Names
SLC44A1; CD92; CDW92; CTL1; Choline transporter-like protein 1; CDw92; Solute carrier family 44 member 1; CD_antigen=CD92
Target/Specificity
This SLC44A1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 247-277 amino acids from the Central region of human SLC44A1.
Dilution
WB~~1:100~500
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
SLC44A1 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

SLC44A1 Antibody (Center) - Protein Information

Name SLC44A1
Synonyms CD92, CDW92, CTL1
Function
Choline transporter. May be involved in membrane synthesis and myelin production
Cellular Location
Cell membrane; Multi-pass membrane protein. Mitochondrion outer membrane; Multi-pass membrane protein
Tissue Location
Expressed in various cells of the hematopoietic system

SLC44A1 Antibody (Center) - Related products

AP14061c: SLC44A1 Antibody (Center)

RI14939: SLC44A1 predesign siRNA

AT3924a: SLC44A1 Antibody (monoclonal) (M02)

SLC44A1 Antibody (Center) - Application data

  • SLC44A1 Antibody (Center) (Cat. #AP14061c) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SLC44A1 antibody detected the SLC44A1 protein (arrow).

  • SLC44A1 Antibody (Center) (AP14061c)immunohistochemistry analysis in formalin fixed and paraffin embedded human spleen tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SLC44A1 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.

SLC44A1 Antibody (Center) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

SLC44A1 is a choline transporter. May be involved in membrane synthesis and myelin production.

REFERENCES

Nakamura, T., et al. Biol. Pharm. Bull. 33(4):691-696(2010) Machova, E., et al. J. Neurochem. 110(4):1297-1309(2009) Michel, V., et al. FASEB J. 23(8):2749-2758(2009) Perry, J.R., et al. Nat. Genet. 41(6):648-650(2009) Yuan, Z., et al. Physiol. Genomics 26(1):76-90(2006)